P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000846496.51905.dd |
| _version_ | 1827335185345019904 |
|---|---|
| author | K. Groen M. Seefat K. Nasserinejad C. A. Stege E. van der Spek Y. M. Bilgin A. Kentos M. Sohne R. J. van Kampen I. Ludwig N. Thielen N. Durdu-Rayman N. C. de Graauw N. W. van de Donk E. G. de Waal M.-C. Vekemans G. J. Timmers M. van der Klift S. Soechit P. A. Geerts M. H. Silbermann M. Oosterveld I. Nijhof P. Sonneveld S. K. Klein M.-D. Levin S. Zweegman |
| author_facet | K. Groen M. Seefat K. Nasserinejad C. A. Stege E. van der Spek Y. M. Bilgin A. Kentos M. Sohne R. J. van Kampen I. Ludwig N. Thielen N. Durdu-Rayman N. C. de Graauw N. W. van de Donk E. G. de Waal M.-C. Vekemans G. J. Timmers M. van der Klift S. Soechit P. A. Geerts M. H. Silbermann M. Oosterveld I. Nijhof P. Sonneveld S. K. Klein M.-D. Levin S. Zweegman |
| author_sort | K. Groen |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:11:20Z |
| format | Article |
| id | doaj.art-de7b33949bb645c785d0c3c2f76a5ff0 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:11:20Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-de7b33949bb645c785d0c3c2f76a5ff02024-03-02T07:47:12ZengWileyHemaSphere2572-92412022-06-01679779810.1097/01.HS9.0000846496.51905.dd202206003-00797P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDYK. Groen0M. Seefat1K. Nasserinejad2C. A. Stege3E. van der Spek4Y. M. Bilgin5A. Kentos6M. Sohne7R. J. van Kampen8I. Ludwig9N. Thielen10N. Durdu-Rayman11N. C. de Graauw12N. W. van de Donk13E. G. de Waal14M.-C. Vekemans15G. J. Timmers16M. van der Klift17S. Soechit18P. A. Geerts19M. H. Silbermann20M. Oosterveld21I. Nijhof22P. Sonneveld23S. K. Klein24M.-D. Levin25S. Zweegman261 Hematology, Amsterdam UMC, Amsterdam1 Hematology, Amsterdam UMC, Amsterdam2 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam1 Hematology, Amsterdam UMC, Amsterdam3 Department of Internal Medicine, Rijnstate Hospital, Arnhem4 Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, Netherlands5 Department of Hematology, Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium6 Department of Internal Medicine/Hematology, St Antonius Hospital, Nieuwegein7 Department of Internal Medicine, Zuyderland Medical Center, Sittard-Geleen8 Department of Hematology, Bernhoven Hospital, Uden9 Department of Internal Medicine, Diakonessenhuis, Utrecht10 Department of Internal Medicine, Franciscus Hospital, location Vlietland, Schiedam11 Department of Internal Medicine, Bravis ziekenhuis, Roosendaal1 Hematology, Amsterdam UMC, Amsterdam12 Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden, Netherlands13 Department of Hematology, St Luc Hospital, Bruxelles, Belgium14 Department of Internal Medicine, Amstelland Hospital, Amstelveen15 Department of Internal Medicine, Amphia Hospital, Breda16 Department of Hematology, Reinier de Graaf Groep, Delft17 Department of Internal Medicine, Deventer Hospital, Deventer19 Department of Internal Medicine, Tergooi Hospital, Hilversum20 Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen1 Hematology, Amsterdam UMC, Amsterdam22 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam23 Department of Internal Medicine, Meander Medical Center, Amersfoort24 Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands1 Hematology, Amsterdam UMC, Amsterdamhttp://journals.lww.com/10.1097/01.HS9.0000846496.51905.dd |
| spellingShingle | K. Groen M. Seefat K. Nasserinejad C. A. Stege E. van der Spek Y. M. Bilgin A. Kentos M. Sohne R. J. van Kampen I. Ludwig N. Thielen N. Durdu-Rayman N. C. de Graauw N. W. van de Donk E. G. de Waal M.-C. Vekemans G. J. Timmers M. van der Klift S. Soechit P. A. Geerts M. H. Silbermann M. Oosterveld I. Nijhof P. Sonneveld S. K. Klein M.-D. Levin S. Zweegman P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY HemaSphere |
| title | P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_full | P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_fullStr | P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_full_unstemmed | P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_short | P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY |
| title_sort | p906 ixazomib daratumumab and low dose dexamethasone in frail patients with newly diagnosed multiple myeloma ndmm results of the maintenance treatment of the phase ii hovon 143 study |
| url | http://journals.lww.com/10.1097/01.HS9.0000846496.51905.dd |
| work_keys_str_mv | AT kgroen p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT mseefat p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT knasserinejad p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT castege p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT evanderspek p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT ymbilgin p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT akentos p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT msohne p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT rjvankampen p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT iludwig p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT nthielen p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT ndurdurayman p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT ncdegraauw p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT nwvandedonk p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT egdewaal p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT mcvekemans p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT gjtimmers p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT mvanderklift p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT ssoechit p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT pageerts p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT mhsilbermann p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT moosterveld p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT inijhof p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT psonneveld p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT skklein p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT mdlevin p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study AT szweegman p906ixazomibdaratumumabandlowdosedexamethasoneinfrailpatientswithnewlydiagnosedmultiplemyelomandmmresultsofthemaintenancetreatmentofthephaseiihovon143study |